Terms: = Prostate cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Diagnosis
29 results:
1. Androgen deprivation therapy caused a drastic proliferation of B-cell lymphoma with IgG4-related disease in patients with prostate cancer: a case report.
Sasagawa H; Numakura K; Mori M; Kobayashi M; Kashima S; Yamamoto R; Nara T; Saito M; Narita S; Nanjo H; Habuchi T
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15091-15094. PubMed ID: 37688628
[TBL] [Abstract] [Full Text] [Related]
2. Bilateral Adrenal and testicular Tumours; When a Simple diagnosis Becomes Complicated.
Grootemaat M; Tjiam I; Sampimon D; Bot F; Roshani H
Urology; 2023 May; 175():e11-e12. PubMed ID: 36828262
[TBL] [Abstract] [Full Text] [Related]
3. Autophagy inhibition and reactive oxygen species elimination by acetyl-CoA acetyltransferase 1 through fused in sarcoma protein to promote prostate cancer.
Guan J; Jiang X; Guo Y; Zhao W; Li J; Li Y; Cheng M; Fu L; Zhao Y; Li Q
BMC Cancer; 2022 Dec; 22(1):1313. PubMed ID: 36517760
[TBL] [Abstract] [Full Text] [Related]
4. [Prostatic Lymphoma: a rare cause of urinary retention (a case report)].
Namaoui RY; Benremouga MC; Boutoura S; Rahali MC; Hadjaoui W; Zerabib A; Belbekri L; Zar F; Berrah H; Mouats A; Bessaïh A
Pan Afr Med J; 2022; 43():33. PubMed ID: 36505021
[TBL] [Abstract] [Full Text] [Related]
5. The Role of Tumor-related LncRNA PART1 in cancer.
Chen J; Meng E; Lin Y; Shen Y; Hu C; Zhou G; Yuan C
Curr Pharm Des; 2021; 27(40):4152-4159. PubMed ID: 34225608
[TBL] [Abstract] [Full Text] [Related]
6. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and cancer Consortium.
Grivas P; Khaki AR; Wise-Draper TM; French B; Hennessy C; Hsu CY; Shyr Y; Li X; Choueiri TK; Painter CA; Peters S; Rini BI; Thompson MA; Mishra S; Rivera DR; Acoba JD; Abidi MZ; Bakouny Z; Bashir B; Bekaii-Saab T; Berg S; Bernicker EH; Bilen MA; Bindal P; Bishnoi R; Bouganim N; Bowles DW; Cabal A; Caimi PF; Chism DD; Crowell J; Curran C; Desai A; Dixon B; Doroshow DB; Durbin EB; Elkrief A; Farmakiotis D; Fazio A; Fecher LA; Flora DB; Friese CR; Fu J; Gadgeel SM; Galsky MD; Gill DM; Glover MJ; Goyal S; Grover P; Gulati S; Gupta S; Halabi S; Halfdanarson TR; Halmos B; Hausrath DJ; Hawley JE; Hsu E; Huynh-Le M; Hwang C; Jani C; Jayaraj A; Johnson DB; Kasi A; Khan H; Koshkin VS; Kuderer NM; Kwon DH; Lammers PE; Li A; Loaiza-Bonilla A; Low CA; Lustberg MB; Lyman GH; McKay RR; McNair C; Menon H; Mesa RA; Mico V; Mundt D; Nagaraj G; Nakasone ES; Nakayama J; Nizam A; Nock NL; Park C; Patel JM; Patel KG; Peddi P; Pennell NA; Piper-Vallillo AJ; Puc M; Ravindranathan D; Reeves ME; Reuben DY; Rosenstein L; Rosovsky RP; Rubinstein SM; Salazar M; Schmidt AL; Schwartz GK; Shah MR; Shah SA; Shah C; Shaya JA; Singh SRK; Smits M; Stockerl-Goldstein KE; Stover DG; Streckfuss M; Subbiah S; Tachiki L; Tadesse E; Thakkar A; Tucker MD; Verma AK; Vinh DC; Weiss M; Wu JT; Wulff-Burchfield E; Xie Z; Yu PP; Zhang T; Zhou AY; Zhu H; Zubiri L; Shah DP; Warner JL; Lopes G
Ann Oncol; 2021 Jun; 32(6):787-800. PubMed ID: 33746047
[TBL] [Abstract] [Full Text] [Related]
7. Urate Nephropathy from Tumor Lysis Syndrome in an Undiagnosed Case of prostate cancer.
Javed S
Curr Oncol; 2021 Jan; 28(1):440-444. PubMed ID: 33450897
[TBL] [Abstract] [Full Text] [Related]
8. Primary diffuse large B cell lymphoma (DLBCL) of the prostate presenting with lower urinary tract symptoms (LUTS).
Nusrat A; Nazim SM
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33370963
[TBL] [Abstract] [Full Text] [Related]
9. Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study.
Ullrich T; Arsov C; Quentin M; Mones F; Westphalen AC; Mally D; Hiester A; Albers P; Antoch G; Schimmöller L
Eur Radiol; 2020 Nov; 30(11):6042-6051. PubMed ID: 32591887
[TBL] [Abstract] [Full Text] [Related]
10. Occurrence of lymphoplasmacytic lymphoma in a chronic myeloid leukemia patient following long-term treatment with tyrosine kinase inhibitors: A case report.
Lee CH; Jeon SY; Yhim HY; Jang KY; Kwak JY
Medicine (Baltimore); 2020 May; 99(19):e19962. PubMed ID: 32384445
[TBL] [Abstract] [Full Text] [Related]
11. [Clinicopathological characterization of non-Hodgkin lymphoma of the prostate].
Zhou XD; Qi RX; Feng X; Liang Y; Wang XX; Bao W; Shi QL
Zhonghua Nan Ke Xue; 2019 Apr; 25(5):340-345. PubMed ID: 32216216
[TBL] [Abstract] [Full Text] [Related]
12. NKX3-1 Is a Useful Immunohistochemical Marker of EWSR1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma.
Yoshida KI; Machado I; Motoi T; Parafioriti A; Lacambra M; Ichikawa H; Kawai A; Antonescu CR; Yoshida A
Am J Surg Pathol; 2020 Jun; 44(6):719-728. PubMed ID: 31972596
[TBL] [Abstract] [Full Text] [Related]
13. A case report of primary prostate intravascular large B cell lymphoma presenting as prostatic hyperplasia.
Zhu F; Pan H; Xiao Y; Li Q; Liu T; Liu X; Wu G; Li J; Zhang L
Medicine (Baltimore); 2019 Dec; 98(50):e18384. PubMed ID: 31852153
[TBL] [Abstract] [Full Text] [Related]
14. Complications and Adverse Events of Three Magnetic Resonance Imaging-based Target Biopsy Techniques in the diagnosis of prostate cancer Among Men with Prior Negative Biopsies: Results from the FUTURE Trial, a Multicentre Randomised Controlled Trial.
Wegelin O; Exterkate L; van der Leest M; Kelder JC; Bosch JLHR; Barentsz JO; Somford DM; van Melick HHE
Eur Urol Oncol; 2019 Nov; 2(6):617-624. PubMed ID: 31519516
[TBL] [Abstract] [Full Text] [Related]
15. Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the prostate?
Exterkate L; Wegelin O; Barentsz JO; van der Leest MG; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; van Melick HHE; Somford DM
Eur Urol Oncol; 2020 Apr; 3(2):216-223. PubMed ID: 31239236
[TBL] [Abstract] [Full Text] [Related]
16. Incidental finding of non-Hodgkin's lymphoma in a patient affected by castration-sensitive prostate cancer: A case report.
Pirozzi A; Cartenì G; Scagliarini S; Fusco M; Riccardi F
Medicine (Baltimore); 2019 Mar; 98(11):e14805. PubMed ID: 30882658
[TBL] [Abstract] [Full Text] [Related]
17. The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the diagnosis of prostate cancer in Patients with Prior Negative Biopsies.
Wegelin O; Exterkate L; van der Leest M; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; Barentsz JO; Somford DM; van Melick HHE
Eur Urol; 2019 Apr; 75(4):582-590. PubMed ID: 30522912
[TBL] [Abstract] [Full Text] [Related]
18. Cognitive Versus Software fusion for MRI-targeted Biopsy: Experience Before and After Implementation of fusion.
Monda SM; Vetter JM; Andriole GL; Fowler KJ; Shetty AS; Weese JR; Kim EH
Urology; 2018 Sep; 119():115-120. PubMed ID: 29940232
[TBL] [Abstract] [Full Text] [Related]
19. Treatment-naïve spontaneous tumor lysis syndrome in metastatic prostate adenocarcinoma: An unusual suspect.
Ignaszewski M; Kohlitz P
Am J Emerg Med; 2017 Sep; 35(9):1384.e1-1384.e2. PubMed ID: 28587951
[TBL] [Abstract] [Full Text] [Related]
20. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
Wegelin O; van Melick HHE; Hooft L; Bosch JLHR; Reitsma HB; Barentsz JO; Somford DM
Eur Urol; 2017 Apr; 71(4):517-531. PubMed ID: 27568655
[TBL] [Abstract] [Full Text] [Related]
[Next]
